Advertisement
YOU ARE HERE: LAT HomeCollectionsMckesson Drug Corp
IN THE NEWS

Mckesson Drug Corp

FEATURED ARTICLES
BUSINESS
September 15, 1993
Biomerica Inc., a maker of home medical testing products, said Tuesday that two of its products are being distributed nationally by McKesson Drug Corp. to about 1,400 pharmacies. The Newport Beach company said its EZ Detect Stool Blood Test and EZ Detect Urine Blood Test, both of which provide warning signs of cancer and other diseases, are being offered to pharmacies through McKesson's network of 40 distribution centers.
ARTICLES BY DATE
BUSINESS
May 8, 2007 | From Times Wire Services
McKesson Corp.'s profit climbed 17% in its fiscal fourth quarter to top analysts' expectations, capping a year of robust growth at the nation's largest distributor of prescription drugs. The San Francisco-based company said it earned $257 million, or 85 cents a share, for the three months ended in March. That compared with net income of $220 million, or 70 cents, a year earlier. Revenue totaled $24.2 billion, a 2% increase.
Advertisement
BUSINESS
May 8, 2007 | From Times Wire Services
McKesson Corp.'s profit climbed 17% in its fiscal fourth quarter to top analysts' expectations, capping a year of robust growth at the nation's largest distributor of prescription drugs. The San Francisco-based company said it earned $257 million, or 85 cents a share, for the three months ended in March. That compared with net income of $220 million, or 70 cents, a year earlier. Revenue totaled $24.2 billion, a 2% increase.
BUSINESS
March 4, 1998 | BARBARA MARSH, TIMES STAFF WRITER
The Federal Trade Commission voted Tuesday to block two mergers in the drug distribution industry that would have left most of the nation's wholesale drug business in the hands of two corporate behemoths. The commission said the deals, if allowed, would significantly reduce competition in the wholesale market for prescription drugs and trigger higher prices for consumers.
BUSINESS
May 28, 1994 | From Times Staff and Wire Reports
Sale of McKesson Expected: The San Francisco-based drug and managed-care health company is likely to be bought soon in a $5-billion deal by either Glaxo Holdings or Johnson & Johnson in a deal with Glaxo, sources said. Analysts say the deal could take place as soon as this weekend. In anticipation of a takeover, McKesson stock closed up $3.375 at $84.75 after gaining $8.625 on Thursday. Rumors pegged the bidding as high as $125 a share.
BUSINESS
March 4, 1998 | BARBARA MARSH, TIMES STAFF WRITER
The Federal Trade Commission voted Tuesday to block two mergers in the drug distribution industry that would have left most of the nation's wholesale drug business in the hands of two corporate behemoths. The commission said the deals, if allowed, would significantly reduce competition in the wholesale market for prescription drugs and trigger higher prices for consumers.
BUSINESS
March 4, 1998 | BARBARA MARSH, TIMES STAFF WRITER
The Federal Trade Commission voted Tuesday to block two mergers in the drug distribution industry that would have left most of the nation's wholesale drug business in the hands of two corporate behemoths. The commission said the deals, if allowed, would significantly reduce competition in the wholesale market for prescription drugs and trigger higher prices for consumers.
BUSINESS
March 4, 1998 | BARBARA MARSH, TIMES STAFF WRITER
The Federal Trade Commission voted Tuesday to block two mergers in the drug distribution industry that would have left most of the nation's wholesale drug business in the hands of two corporate behemoths. The commission said the deals, if allowed, would significantly reduce competition in the wholesale market for prescription drugs and trigger higher prices for consumers.
BUSINESS
May 28, 1994 | From Times Staff and Wire Reports
Sale of McKesson Expected: The San Francisco-based drug and managed-care health company is likely to be bought soon in a $5-billion deal by either Glaxo Holdings or Johnson & Johnson in a deal with Glaxo, sources said. Analysts say the deal could take place as soon as this weekend. In anticipation of a takeover, McKesson stock closed up $3.375 at $84.75 after gaining $8.625 on Thursday. Rumors pegged the bidding as high as $125 a share.
BUSINESS
September 15, 1993
Biomerica Inc., a maker of home medical testing products, said Tuesday that two of its products are being distributed nationally by McKesson Drug Corp. to about 1,400 pharmacies. The Newport Beach company said its EZ Detect Stool Blood Test and EZ Detect Urine Blood Test, both of which provide warning signs of cancer and other diseases, are being offered to pharmacies through McKesson's network of 40 distribution centers.
Los Angeles Times Articles
|